Surging Geriatric Population and Increasing Demand for Antiaging Treatments is Driving the North America Carboxy Therapy Market
The frequency of people aged 65 or above is likely to increase from 1 in 11 in 2019 to 1 in 6 by 2025. According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Therefore, a significant increase in the geriatric population and changes in beauty standards on a regional level have increased the demand for antiaging treatments to reduce fine lines and wrinkles, which helps maintain younger-looking skin for a long time. Aging is an inevitable phenomenon. There has been increased awareness about aesthetics, significantly fueling the demand for antiaging treatments. Additionally, an increase in the geriatric population has created a demand for various types of antiaging and skin rejuvenation treatments. Carboxy therapy ensures the maximum absorption of nutrients and provides healthy skin. Moreover, there has been increased awareness among a large population about personality and appearance, along with the surge in disposable income, which has increased the use of beauty treatments, aiding the North America carboxy therapy market growth.
North America Overview
North American market for carboxy therapy consists of the US, Canada, and Mexico. The North America carboxy therapy market accounted for the largest market share in 2021, owing to various factors such as an increase in demand for antiaging treatments and a surge in non-invasive cosmetic procedures. Moreover, the rise in demand for aesthetics procedures and the constant increase in the geriatric population have driven the market. Additionally, an increase in application areas for carboxy therapy is likely to create ample opportunities in the coming years. As per ASAPS 2020, 15.6 million cosmetic procedures were recorded in 2020, which included approximately 2.3 million cosmetic surgical and 13.2 million cosmetic minimally invasive procedures. In addition, according to the International Society of Aesthetic Plastic Surgery report, 174,300 photo rejuvenation procedures were performed in 2020 in the US. Additionally, the increased application of carboxy therapy in medical fields such as neurology, gynecology, and urology is expected to contribute significantly to the growth of the carboxy therapy market. Therefore, rising number of aesthetic procedures and increasing expenditures are likely to support the market growth and expected to offer ample revenue growth during the forecast period.
North America Carboxy Therapy Market Segmentation
The North America carboxy therapy market is segmented into type, application, end user, and country.
Based on type, the North America carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment is expected to hold the largest market share by 2022.
Based on application, the North America carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rheumatology, sports medicine, and others. The aesthetic medicine segment is expected to hold the largest market share by 2022. The aesthetic medicine segment is further sub segmented into cellulite, stretch marks, alopecia, and dark under-eye circles.
Based on end user, the North America carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. The hospitals segment is expected to hold the largest market share by 2022.
Based on country, the North America carboxy therapy market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.
Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; Mezopharma; and Nick Fanavaran Plasma Company are among the leading companies operating in the North America carboxy therapy market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 36.35 Million |
| Market Size by 2028 | US$ 72.69 Million |
| CAGR (2022 - 2028) | 12.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
The North America Carboxy Therapy Market is valued at US$ 36.35 Million in 2022, it is projected to reach US$ 72.69 Million by 2028.
As per our report North America Carboxy Therapy Market, the market size is valued at US$ 36.35 Million in 2022, projecting it to reach US$ 72.69 Million by 2028. This translates to a CAGR of approximately 12.2% during the forecast period.
The North America Carboxy Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Carboxy Therapy Market report:
The North America Carboxy Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Carboxy Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Carboxy Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For North America Carboxy Therapy Market
